Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 346 AL 360

AVP-786 for the treatment of agitation in dementia of the Alzheimer's type

Garay RP, Grossberg GT.

Expert Opin Investig Drugs. 2017 Jan;26(1):121-132. doi: 10.1080/13543784.2017.1267726. Epub 2016 Dec 11.

MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease

Regan B, Wells Y, Farrow M, O'Halloran P, Workman B.

Am J Geriatr Psychiatry. 2017 Mar;25(3):258-269. doi: 10.1016/j.jagp.2016.11.008. Epub 2016 Nov 16.

Non human primate models for Alzheimer's disease-related research and drug discovery

Van Dam D, De Deyn PP.

Expert Opin Drug Discov. 2017 Feb;12(2):187-200. doi: 10.1080/17460441.2017.1271320. Epub 2016 Dec 25.

Program Components and Outcomes of Individuals With Dementia: Results From the Replication of an Evidence-Based Program

Menne HL, Bass DM, Johnson JD, Kearney KR, Bollin S, Teri L.

J Appl Gerontol. 2017 May;36(5):537-552. doi: 10.1177/0733464815591212. Epub 2015 Jun 16.

Yoga and compassion meditation program improve quality of life and self-compassion in family caregivers of Alzheimer's disease patients: A randomized controlled trial

Danucalov MA, Kozasa EH, Afonso RF, Galduroz JC, Leite JR.

Geriatr Gerontol Int. 2017 Jan;17(1):85-91. doi: 10.1111/ggi.12675. Epub 2015 Dec 21.

IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia

Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Chan M, Ghassemi A.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):106-112. doi: 10.1136/jnnp-2015-311486. Epub 2015 Sep 29.

Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?

Bali P, Lahiri DK, Banik A, Nehru B, Anand A.

Curr Alzheimer Res. 2017;14(2):208-220. doi: 10.2174/1567205013666160314145347.

Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease

Mondragón-Rodríguez S, Perry G, Pena-Ortega F, Williams S.

Curr Alzheimer Res. 2017;14(1):40-46. doi: 10.2174/1567205013666160819131336.

Deep Brain Stimulation for Alzheimer's Disease

Xu DS, Ponce FA.

Curr Alzheimer Res. 2017;14(4):356-361. doi: 10.2174/1567205013666161014124945.

Nanomedicine in brain repair: Alzheimer's, Parkinson's and the proteome

Broderick PA, Jacoby JH.

J Neural Transm (Vienna). 2017 Jan;124(1):1. doi: 10.1007/s00702-016-1660-0.

Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies

Ciceri F, Rotllant D, Maes T.

Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.

Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, Sobarzo-Sanchez E, Nabavi SF.

CNS Neurol Disord Drug Targets. 2017;16(4):387-397. doi: 10.2174/1871527316666170328113309.

Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM.

Pharm Res. 2017 Dec;34(12):2614-2627. doi: 10.1007/s11095-017-2199-y. Epub 2017 Jun 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias